165 related articles for article (PubMed ID: 10528081)
1. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins.
Han J; Lim SJ; Lee MK; Kim CK
Drug Deliv; 2001; 8(3):125-34. PubMed ID: 11570592
[TBL] [Abstract][Full Text] [Related]
3. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.
Stehle G; Sinn H; Wunder A; Schrenk HH; Schütt S; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Aug; 8(7):677-85. PubMed ID: 9311444
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.
Stehle G; Wunder A; Sinn H; Schrenk HH; Schütt S; Frei E; Hartung G; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Oct; 8(9):835-44. PubMed ID: 9402310
[TBL] [Abstract][Full Text] [Related]
5. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
Yuan SH; Ge WH; Huo J; Wang XH
Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
Kim CK; Han JH
J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
Muvaffak A; Gurhan I; Gunduz U; Hasirci N
J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
10. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
[TBL] [Abstract][Full Text] [Related]
11. In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells.
Murawala P; Tirmale A; Shiras A; Prasad BL
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():158-67. PubMed ID: 24268245
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin.
Dube D; Khatri K; Goyal AK; Mishra N; Vyas SP
Drug Dev Ind Pharm; 2010 May; 36(5):547-55. PubMed ID: 19895190
[TBL] [Abstract][Full Text] [Related]
14. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
15. A micelle-like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery.
Ren J; Fang Z; Yao L; Dahmani FZ; Yin L; Zhou J; Yao J
Int J Pharm; 2015 Jun; 487(1-2):177-86. PubMed ID: 25865570
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
[TBL] [Abstract][Full Text] [Related]
17. Induction of Au-methotrexate conjugates by sugar molecules: production, assembly mechanism, and bioassay studies.
Wang WY; Zhao XF; Ju XH; Liu P; Li J; Tang YW; Li SP; Li XD; Song FG
Int J Pharm; 2018 Mar; 538(1-2):65-78. PubMed ID: 29341908
[TBL] [Abstract][Full Text] [Related]
18. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
[TBL] [Abstract][Full Text] [Related]
19. Characterization of in-vitro drug release and biological activity of methotrexate-bovine serum albumin conjugates.
Halbert GW; Florence AT; Stuart JF
J Pharm Pharmacol; 1987 Nov; 39(11):871-6. PubMed ID: 2892908
[TBL] [Abstract][Full Text] [Related]
20. Study of biodistribution of methotrexate-loaded bovine serum albumin nanospheres in mice.
Santhi K; Dhanaraj SA; Koshy M; Ponnusankar S; Suresh B
Drug Dev Ind Pharm; 2000 Dec; 26(12):1293-6. PubMed ID: 11147130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
